LGVN
Price
$0.79
Change
+$0.04 (+5.33%)
Updated
Sep 5 closing price
Capitalization
16.47M
PROK
Price
$2.25
Change
-$0.05 (-2.17%)
Updated
Sep 5 closing price
Capitalization
303.74M
73 days until earnings call
Interact to see
Advertisement

LGVN vs PROK

Header iconLGVN vs PROK Comparison
Open Charts LGVN vs PROKBanner chart's image
Longeveron
Price$0.79
Change+$0.04 (+5.33%)
Volume$394.15K
Capitalization16.47M
ProKidney
Price$2.25
Change-$0.05 (-2.17%)
Volume$1.4M
Capitalization303.74M
LGVN vs PROK Comparison Chart in %
Loading...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LGVN vs. PROK commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGVN is a Hold and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (LGVN: $0.79 vs. PROK: $2.25)
Brand notoriety: LGVN and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LGVN: 31% vs. PROK: 8%
Market capitalization -- LGVN: $16.47M vs. PROK: $303.74M
LGVN [@Biotechnology] is valued at $16.47M. PROK’s [@Biotechnology] market capitalization is $303.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LGVN’s FA Score shows that 1 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • LGVN’s FA Score: 1 green, 4 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, LGVN is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LGVN’s TA Score shows that 4 TA indicator(s) are bullish while PROK’s TA Score has 3 bullish TA indicator(s).

  • LGVN’s TA Score: 4 bullish, 6 bearish.
  • PROK’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both LGVN and PROK are a bad buy in the short-term.

Price Growth

LGVN (@Biotechnology) experienced а -4.38% price change this week, while PROK (@Biotechnology) price change was -4.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

PROK is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PROK($304M) has a higher market cap than LGVN($16.5M). PROK YTD gains are higher at: 33.136 vs. LGVN (-54.231). LGVN has higher annual earnings (EBITDA): -18.35M vs. PROK (-157.52M). PROK has more cash in the bank: 295M vs. LGVN (10.3M). LGVN has less debt than PROK: LGVN (1.14M) vs PROK (4.42M). LGVN has higher revenues than PROK: LGVN (2.07M) vs PROK (527K).
LGVNPROKLGVN / PROK
Capitalization16.5M304M5%
EBITDA-18.35M-157.52M12%
Gain YTD-54.23133.136-164%
P/E Ratio3.17N/A-
Revenue2.07M527K393%
Total Cash10.3M295M3%
Total Debt1.14M4.42M26%
TECHNICAL ANALYSIS
Technical Analysis
LGVNPROK
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
69%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
65%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
69%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 10 days ago
73%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
65%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TOELY68.390.12
+0.18%
Tokyo Electron Ltd.
KICK8.75N/A
N/A
HPN Holdings, Inc.
JNBYF2.09N/A
N/A
JNBY Design Ltd.
SFGIF10.51N/A
N/A
SHIZUOKA FINL GROUP INC.
IHLDF0.11N/A
-0.05%
Immutable Holdings Inc.

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with QURE. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
+5.84%
QURE - LGVN
38%
Loosely correlated
+1.24%
RXRX - LGVN
36%
Loosely correlated
+1.99%
SNGX - LGVN
36%
Loosely correlated
-5.92%
HRTX - LGVN
35%
Loosely correlated
-0.76%
PROK - LGVN
34%
Loosely correlated
-2.17%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with CYCC. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then CYCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
-2.17%
CYCC - PROK
57%
Loosely correlated
-4.56%
MBIO - PROK
51%
Loosely correlated
-2.72%
RLYB - PROK
45%
Loosely correlated
+3.86%
RYTM - PROK
40%
Loosely correlated
-2.34%
NRIX - PROK
39%
Loosely correlated
+8.66%
More